Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 192.34 +4.88 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $187.46 | 52 Week High | $0.52 | |||
| Open | $183.65 | 52 Week Low | $0.08 | |||
| Day High | $193.99 | P/E | N/A | |||
| Day Low | $182.50 | EPS | $-3.80 | |||
| Volume | 7,337,139 | |||||
